6505-01-099-4064 ( NDC49884-0959-01 , NDC51079-0375-21 , NDC00555-0033-02 , NDC00187-3751-10 , NDC00591-0786-01 , NDC51079-0375-20 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-099-4064 | 6505 | 010994064 | CHLORDIAZEPOXIDE HYDROCHLORIDE C | 3079 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| ECWT | EXTERIOR CONTAINER WEIGHT | 17.00 POUNDS |
| CSCX | TOTAL SECONDARY CONTAINER QUANTITY | 4 |
| PKTY | UNIT PACKAGE TYPE | PACKAGE |
| CQLS | CAPSULE CONTENT FORM | POWDER |
| FEAT | SPECIAL FEATURES | REVERSE-NUMBERED ROLLED STRIPS |
| CRXL | PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 1 STRIP, ROLL |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 10MG I.S. 100S |
| AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 25.000 |
| SUWT | UNIT OF ISSUE WEIGHT | 0.21 POUNDS |
| SUCB | UNIT OF ISSUE CUBE | 0.212 CUBIC FEET |
| PKQT | INTERMEDIATE PACKAGE QUANTITY | 10 |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 10.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT |
| EXQT | EXTERIOR CONTAINER QUANTITY | 80 |
| SUPP | SUPPLEMENTARY FEATURES | CONSISTS OF 4 BOXES EA CONTAINING 25 CAPSULES |
| CQCT | PRIMARY CONTAINER TYPE | STRIP, ROLL |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 4 |
| EXME | EXTERIOR CONTAINER CUBIC MEASURE | 1.693 CUBIC FEET |
| CQGK | SECONDARY CONTAINER TYPE | BOX |
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
| AKJC | CAPSULE TYPE | HARD |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC49884-0959-01 | 0VZ14 | A | 2 | 5 | 4 | ZZ | |
| NDC51079-0375-21 | 65751 | A | 1 | 3 | 4 | ZZ | |
| NDC00555-0033-02 | 56490 | A | 1 | 5 | 4 | ZZ | |
| NDC00187-3751-10 | 3AWU3 | A | 2 | 5 | 4 | ZZ | |
| NDC00591-0786-01 | 62051 | A | 1 | 5 | 4 | ZZ | |
| NDC51079-0375-20 | 65751 | A | 2 | 5 | 4 | ZZ |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC49884-0959-01 | 0VZ14 | PAR PHARMACEUTICAL INC. | F | A |
| NDC51079-0375-21 | 65751 | UDL LABORATORIES, INC. | A | A |
| NDC00555-0033-02 | 56490 | BARR LABORATORIES INC. | A | A |
| NDC00187-3751-10 | 3AWU3 | VALEANT PHARMACEUTICALS | A | A |
| NDC00591-0786-01 | 62051 | DANBURY PHARMACAL INC | A | A |
| NDC51079-0375-20 | 65751 | UDL LABORATORIES, INC. | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 08/19/1 | P | 3004400020 | 3079 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DS | I | K | U/I CONTAINS 100 EA | ||
| DA | C2201X- | A | K | U/I CONTAINS 100 EA | |
| DF | ------- | F | K | U/I CONTAINS 100 EA | |
| DN | 9B----- | N | K | U/I CONTAINS 100 EA |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DN | SMS | L | 1 | PG | Q | Q | 9B----- | N | |
| DS | SMS | L | 1 | PG | Q | Q | D | ||
| DF | SMS | L | 1 | PG | Q | Q | ------- | F | |
| DA | SMS | L | 1 | PG | Q | Q | C2201X- | A |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|---|---|---|---|
| C | 2 | 2 | 01 | X |
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 058770 | Z | 33400 | W | 532 | Z | 6 | A | M | Y | DRUGS/MEDICINES/VITAMINS NOI |